New meta-scientific review questions the evidence for the gold standard psychotherapies and empirically supported treatments.
Researchers shed light on the precarious nature of evidence from efficacy trials of antidepressant medication to treat symptoms of major depressive disorder in children and adolescents.
A new study, published in Acta Psychiatrica Scandinavica, found that antidepressant efficacy was not dependent on severity.
Dr. Madhukar Trivedi and colleagues find that the SSRI sertraline does not reduce depressive symptoms any more than placebo in people with Chronic Kidney Disease.
Antidepressants are commonly considered safe and effective treatments. However, research has questioned their efficacy, and now, their safety.
An article published this month in the journal BMC Psychiatry suggests that there is a lack of efficacy for SSRIs and that they significantly increase the risk of serious side effects.
The Atlantic web site has just published a strange piece on the efficacy of the antidepressants. When getting into a discussion with about antidepressants with a...